Introduction
============

Papillary thyroid carcinoma (PTC) is the most common malignancy of the endocrine system, accounting for \~80% of all thyroid malignancies.[@b1-ott-9-4053] PTC is ranked the fifth leading malignancy in females and has a favorable prognosis in most cases.[@b2-ott-9-4053] Conventional open thyroidectomy has been exercised worldwide for the treatment of endocrine neck surgery with low morbidity and mortality.[@b3-ott-9-4053] The first endoscopic thyroidectomy was conducted by Huscher et al[@b4-ott-9-4053] in 1997. With the improvement in minimally invasive surgery, various types of endoscopic thyroidectomy evolved considerably over the past 20 years. The newly developed endoscopic thyroidectomy has been demonstrated to achieve good results and advantages.[@b5-ott-9-4053],[@b6-ott-9-4053] The emergence of endoscopic thyroidectomy technologies provides a promising approach for the treatment of neck diseases. The recently identified endoscopic operative methods, such as axillary,[@b7-ott-9-4053] breast,[@b8-ott-9-4053] and anterior chest approaches,[@b9-ott-9-4053] were successfully applied to thyroidectomy by many surgeons. The endoscopic thyroid surgery was initially appropriate only for benign thyroid diseases; owing to this, a complete thyroidectomy is not sufficiently conducted via endoscopic methods. However, there are several reasons for the clinical applications of endoscopic thyroidectomy: 1) the PTC has a relatively good prognosis;[@b10-ott-9-4053] 2) popularity of endoscopic thyroidectomy with reduced neck scarring and increased cosmetic effect; 3) enhancing cosmetic demand in more females; and 4) the introduction of transaxillary or axillary-breast gasless approach.[@b11-ott-9-4053] The totally endoscopic thyroidectomy is gradually developed in thyroid malignancies. The indications for endoscopic thyroidectomy for the treatment of thyroid malignancies are increasingly expanding with the improvement in the techniques. As the experience of single-port access laparoscopic surgery is accumulating, it has been served as a less-invasive alternative to conventional laparoscopy. An increasing attention has been paid to the postoperative symptoms and functional outcomes in minimally invasive endoscopic thyroidectomy. The present study was conducted to assess the effects of single-port access transaxillary totally endoscopic thyroidectomy on the postoperative outcomes and functional parameters, including quality of life (QOL) and cosmetic result, in patients with PTC.

Patients and methods
====================

Patients and surgical treatment
-------------------------------

This study protocol was approved by the ethics committee of The First Affiliated Hospital of Bengbu Medical College, and the written informed consent concerning the surgical risks was obtained from all the subjects. All experiments were performed in accordance with relevant guidelines and regulations. From May 2009 to December 2012, 75 patients with PTC were subjected to single-port endoscopic thyroidectomy via axillary approach. Moreover, a total of 123 patients with PTC in the same period who were subjected to conventional open total thyroidectomy served as the control group. The enrollment inclusion criteria were set as follows: 1) underwent total thyroidectomy; 2) \>18 years old; 3) no recurrence or persistent disease during the time of evaluation; 4) no history of thyroiditis, neck surgery, or radiation therapy; 5) tumor size \<3 cm; 6) no evidence of lymph node metastasis or local invasion on preoperative ultrasonography; and 7) underwent computed tomography and physical examination. The exclusion criteria were preoperative evidence of nodal disease or lymph node dissection of any lateral compartment during the initial operative intervention, distant metastasis, concomitant lateral neck dissection, and recurrent laryngeal nerve, and patients lost within 1 year of follow-up. The summary of patient's characteristics is listed in [Table 1](#t1-ott-9-4053){ref-type="table"}. All surgical procedures were carried out by one group of surgeons, and all clinicopathological data for this study were collected and analyzed in the database. In addition, all patients enrolled in this study were asked to complete the evaluation of cosmetic and satisfaction outcomes with the aid of University of Washington QOL (UW-QOL) questionnaire, Patient Scar Assessment Questionnaire (PSAQ), and 36-Item Short Form Health Survey (SF-36) questionnaire. The single-port endoscopic thyroidectomy via axillary approach was performed as previously reported.[@b12-ott-9-4053]

Assessment of health-related quality of life
--------------------------------------------

The QOL after differentiated thyroid carcinoma therapy has been increasingly focused during long-term cancer surveillance. The health-related quality of life (HRQOL), including social, emotional, psychological, and spiritual well-being, in patients with PTC were evaluated by the UW-QOL questionnaire.[@b13-ott-9-4053] The UW-QOL questionnaire was a commonly used, self-administered, multifactorial tool to assess the HRQOL of patients with head and neck cancer. The physiological functions, including chewing, swallowing, speech, taste, saliva, and appearance, were calculated as the average of six domain scores. The social functions, including anxiety, mood, pain, activity, recreation, and shoulder function, were also computed as the average of six domain scores. The average of 12 domain scores was recognized as the total composite score. The score ranged from 0 to 100; a score of 0 represented the worst QOL, and a score of 100 served as the best QOL. The assessment of HRQOL was performed after single-port access transaxillary totally endoscopic thyroidectomy.

Evaluation of cosmetic and satisfaction outcomes
------------------------------------------------

Data about the cosmetic result and the overall satisfaction were collected and evaluated by the PSAQ and SF-36 questionnaire, respectively, as previously described.[@b14-ott-9-4053] The PSAQ was a method to measure the perception of scarring in each patient, which involved four subscales: scar appearance, consciousness, satisfaction with scar appearance, and satisfaction with scar symptoms. A lower PSAQ score represented a better outcome. The SF-36 questionnaire was used to assess the burden of surgery. The SF-36 questionnaire was designed to be a multipurpose, short-form health survey in the evaluation of patient's QOL, and it comprised eight subscales such as physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health. A higher score reflected a better outcome.

Statistical analysis
--------------------

All data about continuous variables were expressed as mean ± SD. The Kolmogorov--Smirnov test was used to check the data distribution normality. All the domains, items, and factors in the UW-QOL questionnaire, PSAQ, and SF-36 questionnaire were made by the Mann--Whitney *U*-test. The test for categorical variables was done by the chi-square test, and the small-cell variables were compared by the Fisher's exact test. All statistical analyses were conducted with SPSS 19.0.1 software (IBM Corporation, Armonk, NY, USA). A value of *P*\<0.05 was considered statistically significant.

Results
=======

Clinicopathologic characteristics of the patients in the two groups
-------------------------------------------------------------------

The clinicopathologic characteristics of two groups are summarized in [Table 1](#t1-ott-9-4053){ref-type="table"}. All patients confirmed to diagnose to PTC (PTC) by the final histology report. Seventy-five patients who matched the inclusion criteria successfully underwent endoscopic thyroidectomy via the axillary approach, and 123 patients with PTC received conventional open total thyroidectomy therapy. They all completed the questionnaire. No patient had to be subjected to a conventional approach. The baseline clinical data and demographics were similar in the two groups. There were no statistically significant differences between the two groups in sex, age, body mass index (BMI), education, marital status, tumor size, tumor, node, metastasis (TNM) stage, capsule invasion, extrathy-roid, multiplicity, lymph node metastasis and the number of retrieved lymph nodes. However, the mean operation time was significantly increased in the experimental group.

QOL after single-port access endoscopic thyroidectomy via axillary approach
---------------------------------------------------------------------------

As shown in [Table 2](#t2-ott-9-4053){ref-type="table"}, the physiological functions, including chewing, swallowing, saliva, and appearance, were obviously increased after 6 months of surgery in comparison with after 1 month of surgery in both the control group and experimental group. The social functions, including activity, anxiety, mood, pain, recreation, and shoulder function, were also remarkably augmented after 6 months of surgery in the two groups. However, there was no significant difference in the scores of speech and taste between the two groups in the indicated time of 1 month and 6 months. It is interesting that the mean scores of appearance and physical composite score were significantly higher in the experimental group than those in the control group at the same period of 1 month and 6 months postsurgery.

Cosmetic result and overall satisfaction after single-port access endoscopic thyroidectomy via axillary approach
----------------------------------------------------------------------------------------------------------------

As indicated in [Table 3](#t3-ott-9-4053){ref-type="table"}, with regard to PASQ, compared with after 1 month of surgery, the appearance, consciousness, satisfaction with appearance, and satisfaction with symptoms were significantly decreased after 6 months of surgery in the two groups. The scores for the SF-36 domains of physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health were significantly higher after 6 months of surgery in comparison with after 1 month of surgery in both groups. In addition, the scores for appearance, satisfaction with appearance, role-physical, bodily pain, and general health were better in the experimental group than in the control group after 1 month or 6 months of surgery.

Operative outcomes and postoperative complications
--------------------------------------------------

The postoperative complications included transient vocal cord palsy, bucking, paresthesia, bleeding, seroma, and infection, each of which was treated with conservative care and resolved within 6 months. A total of three cases of transient vocal cord palsy, three cases of bucking, two cases of bleeding, two cases of seroma, and one case of infection were observed in the control group. Alternatively, two cases of transient vocal cord palsy, one case of bucking, two cases of paresthesia, three cases of bleeding, one case of seroma, and two cases of infection occurred in the experimental group. The postoperative complications showed no significant differences between the two groups.

Discussion
==========

A number of studies have indicated the exact role of transaxillary endoscopic thyroidectomy in thyroid diseases.[@b15-ott-9-4053],[@b16-ott-9-4053] The transaxillary endoscopic thyroidectomy is usually applied to patients with differentiated thyroid cancer who had no invasion to peripheral structure or lateral lymph node metastasis.[@b17-ott-9-4053] With the improvements in transaxillary endoscopic thyroidectomy, the indications for transaxillary endoscopic thyroidectomy have been extended to minimal metastatic thyroid cancer. A single-port access transaxillary totally endoscopic thyroidectomy has been employed as an important approach in thyroid diseases.[@b12-ott-9-4053] The present study confirmed that the single-port access transaxillary totally endoscopic thyroidectomy can achieve good physiological functions and favorable social functions in patients with PTC.

With the development in surgical techniques and accumulation in surgical experiences, the feasibility and safety of endoscopic thyroidectomy have been growing in the treatment of thyroid diseases.[@b18-ott-9-4053],[@b19-ott-9-4053] The incidence rate of thyroid tumors is recently increasing in people, especially in young women.[@b20-ott-9-4053] The therapeutic effects of the thyroid tumors are not only focused but also the patients are increasingly interested in the cosmetic satisfaction and postoperative QOL. Although the technical limitations of endoscopic thyroidectomy have been reviewed in large series of patients, the newly developed endoscopic operative methods, including the transaxillary or axillary-breast gasless approach, the bilateral axillary-breast approach, the postauricular and axillary approach, the facelift gasless approach, and the infraclavicular approach, were introduced to clinical therapy of thyroid disease.[@b21-ott-9-4053] Among them, the transaxillary approach is one of the most frequently used. A single-port access transaxillary totally endoscopic thyroidectomy seems to be safe and feasible in benign thyroid tumors.[@b12-ott-9-4053] It is accepted that the PTC has a relatively favorable prognosis with a 10-year survival exceeding 90%.[@b22-ott-9-4053] A host of papers have reported that the total endoscopic thyroidectomy via a transaxillary approach can be applied to PTC therapy.[@b23-ott-9-4053] In the present study, we introduced the single-port access transaxillary totally endoscopic thyroidectomy to PTC surgery. There were no statistically significant differences between the two groups in sex, age, BMI, education, marital status, tumor size, TNM stage, capsule invasion, extrathyroid, multiplicity, lymph node metastasis, and the number of retrieved lymph nodes. However, the mean operation time was significantly increased in the group of single-port access transaxillary totally endoscopic thyroidectomy. This may be attributed to two reasons: 1) the control of meticulous bleeding and lymph node dissection may require longer operation times without using drains and 2) most surgeries were conducted with the aid of unskilled assistants. Meanwhile, the longer operation time may be positively correlated with the increased postoperative complications and morbidity from general anesthesia. Although the longer operation time was one of the disadvantages of this technique, it can be decreased with more surgical experience.[@b6-ott-9-4053],[@b24-ott-9-4053]

The UW-QOL questionnaire is usually used to assess the HRQOL in patients with head and neck cancer.[@b25-ott-9-4053] The HRQOL assessments are frequently performed in patients with differentiated thyroid carcinoma. The HRQOL is verified to be worse than that of the healthy population, despite the excellent prognosis of differentiated thyroid carcinoma.[@b26-ott-9-4053] Compared with conventional thyroidectomy, the higher HRQOL scores are found in robotic thyroidectomy treatment of PTC.[@b23-ott-9-4053] A study showed that psychological problems, memory loss, and migraine headaches occurred in 518 thyroid cancer survivors who underwent thyroidectomy.[@b27-ott-9-4053] Thus, both survival rate and good HRQOL should be preserved in the therapy of thyroid cancer. In the present study, we found that the physiological functions and social functions in the two groups were remarkably augmented after 6 months of surgery. However, there was no significant difference in the scores of speech and taste between the two groups in the indicated time of 1 month and 6 months. It is interesting that the mean scores of appearance and physical composite score were significantly higher in the experimental group than those in the control group at the same period of 1 month and 6 months postsurgery. These results indicated that single-port access transaxillary totally endoscopic thyroidectomy is helpful for recovery of social, emotional, psychological, and spiritual well-being in subjects with PTC.

The PSAQ is specifically designed to evaluate the scar.[@b28-ott-9-4053] With regard to PASQ, compared with after 1 month of surgery, the appearance, consciousness, satisfaction with appearance, and satisfaction with symptoms were significantly decreased after 6 months of surgery in the two groups. A single-port access transaxillary totally endoscopic thyroidectomy exhibited a favored appearance and satisfaction with scar appearance scores in patients with PTC, because the axillary skin incision was made in the border of the pectoralis major muscle with no exposure to natural skin folds.

Scores for the SF-36 domains of physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health were significantly higher after 6 months of surgery in comparison with those after 1 month of surgery in both the two groups. In addition, the scores for appearance, satisfaction with appearance, role physical, bodily pain, and general health in the experimental group were better than those in the control group after 1 month or 6 months of surgery. These results further suggested that the patients who underwent single-port access transaxillary totally endoscopic thyroidectomy were satisfied with their scars and had a better perception of their general state of health and were likely to participate in social activities. The endoscopic thyroidectomy via remote access has been suggested to be cosmetic, but it is not still recognized as minimally invasive due to adequate exposure of the lesion in the surgery. The three ports access the developed endoscopic thyroidectomy based on the previous endoscopic thyroidectomy, and it was separately located on the thorax or breasts with formation of three subcutaneous tunnels within the anterior neck. A single-incision endoscopic thyroidectomy was developed on the basis of multiple-incision techniques and was designed to further improve the cosmetic results and obtain minimally invasive values. In our present study, we dissected a smaller and more hidden area of the subcutaneous tissue with the aid of a single tunnel with the incision placed below the armpit with fewer invasions and less pain after operation. It neatly realized the aims of minimal invasion and improvement in postoperative functional outcomes, including cosmesis and postoperative QOL.

Conclusion
==========

We established the feasibility, safety, and favorable surgical outcomes of single-port access transaxillary totally endoscopic thyroidectomy for treatment of patients with PTC. The developing less invasive instruments and surgical techniques of single-port access transaxillary totally endoscopic thyroidectomy have high cosmetic satisfaction with neck appearance, reduction in injury to the anterior neck tissue. The subjects who underwent this technique had a good perception of their general state of health and were likely to participate in social activities. A single-port access transaxillary totally endoscopic thyroidectomy shows not only the improvement in several incisions but also the perfect combination of cosmetic results and minimally invasive surgery in the field of thyroid surgery.
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###### 

Clinicopathologic characteristics of the patients

  Characteristics                               Control group (n=123)   Experimental group (n=75)                               *P*-value
  --------------------------------------------- ----------------------- ------------------------------------------------------- -----------
  Sex, n (%)                                                                                                                    
   Male                                         31 (25.2)               16 (21.3)                                               0.535
   Female                                       92 (74.8)               59 (78.7)                                               
  Age, years (mean ± SD)                        39.2±11.3               37.8±10.6                                               0.274
  BMI (mean ± SD)                               22.1±3.2                21.6±2.8                                                0.317
  Education, n/N (%)                                                                                                            
   More than high school graduate               67/123 (54.5)           37/75 (49.3)                                            0.482
  Marital status, n/N (%)                                                                                                       
   Married                                      96/123 (78.0)           64/75 (85.3)                                            0.207
  Subjective financial status, n/N (%)                                                                                          
   Low                                          13/123 (10.6)           7/75 (9.3)                                              0.780
   Middle                                       109/123 (88.6)          68/75 (90.7)                                            0.650
   High                                         1/123 (0.8)             0/75 (0)                                                0.434
  Tumor size, cm (mean ± SD)                    0.49±0.23               0.48±0.19                                               0.179
  TNM stage, n/N (%)                                                                                                            
   I                                            34/123 (27.6)           24/75 (32.0)                                            0.513
   II                                           59/123 (48.0)           33/75 (44.0)                                            0.587
   III                                          30/123 (24.4)           14/75 (18.7)                                            0.347
   IV                                           7/123 (5.7)             4/75 (5.3)                                              0.915
  Capsule invasion, n/N (%)                     10/123 (8.1)            6/75 (8.0)                                              0.974
  Extrathyroid, n/N (%)                         4/123 (3.3)             2/75 (2.7)                                              0.816
  Multiplicity, n/N (%)                         9/123 (7.3)             5/75 (6.7)                                              0.863
  Lymph node metastasis, n/N (%)                11/123 (8.9)            9/75 (12.0)                                             0.489
  Number of retrieved lymph nodes (mean ± SD)   3.82±2.41               3.78±2.17                                               0.142
  Operative time, minutes (mean ± SD)           111.5±21.2              142.5±36.9[\*](#tfn1-ott-9-4053){ref-type="table-fn"}   0.003
  Blood loss (mean ± SD)                        17.5±7.4                15.8±6.3                                                0.089
  Follow-up period, months (mean ± SD)          52.4±17.3               50.6±13.8                                               0.113

**Note:**

*P*\<0.05 vs the control group.

**Abbreviations:** BMI, body mass index; TNM, tumor, node, metastasis; SD, standard deviation.

###### 

Mean scores on the UW-QOL questionnaire

  Factor                     1 month after surgery   6 months after surgery                                                                                         
  -------------------------- ----------------------- ------------------------------------------------------- ------------------------------------------------------ ----------------------------------------------------------------------------------------------------
  Pain                       82.3±11.4               85.6±9.5                                                91.8±12.3[\*](#tfn4-ott-9-4053){ref-type="table-fn"}   94.5±12.2[\*](#tfn4-ott-9-4053){ref-type="table-fn"}
  Appearance                 42.3±9.5                65.7±7.8[\*\*](#tfn5-ott-9-4053){ref-type="table-fn"}   75.7±10.2[\*](#tfn4-ott-9-4053){ref-type="table-fn"}   86.2±9.3[\*](#tfn4-ott-9-4053){ref-type="table-fn"},[\*\*](#tfn5-ott-9-4053){ref-type="table-fn"}
  Activity                   73.1±11.4               75.8±9.3                                                86.5±11.4[\*](#tfn4-ott-9-4053){ref-type="table-fn"}   89.8±10.5[\*](#tfn4-ott-9-4053){ref-type="table-fn"}
  Recreation                 65.8±8.4                69.8±7.5                                                90.6±12.9[\*](#tfn4-ott-9-4053){ref-type="table-fn"}   95.6±13.6[\*](#tfn4-ott-9-4053){ref-type="table-fn"}
  Swallowing                 84.6±9.3                85.6±7.5                                                90.2±13.1[\*](#tfn4-ott-9-4053){ref-type="table-fn"}   95.3±11.3[\*](#tfn4-ott-9-4053){ref-type="table-fn"}
  Chewing                    82.2±11.5               80.3±13.9                                               88.4±12.8                                              93.2±15.8[\*](#tfn4-ott-9-4053){ref-type="table-fn"}
  Speech                     90.5±13.1               92.4±11.8                                               92.7±13.1                                              96.8±13.7
  Shoulder                   71.4±7.5                74.2±8.2                                                88.4±12.5[\*](#tfn4-ott-9-4053){ref-type="table-fn"}   90.3±16.9[\*](#tfn4-ott-9-4053){ref-type="table-fn"}
  Taste                      85.5±12.7               90.6±15.3                                               89.3±10.7                                              92.6±11.7
  Saliva                     74.6±9.8                80.3±11.4                                               89.4±11.5[\*](#tfn4-ott-9-4053){ref-type="table-fn"}   92.5±13.8[\*](#tfn4-ott-9-4053){ref-type="table-fn"}
  Humor                      74.6±9.4                76.7±8.5                                                85.3±8.8[\*](#tfn4-ott-9-4053){ref-type="table-fn"}    88.4±9.7[\*](#tfn4-ott-9-4053){ref-type="table-fn"}
  Anxiety                    68.8±8.3                70.5±10.5                                               81.6±10.5[\*](#tfn4-ott-9-4053){ref-type="table-fn"}   85.4±12.7[\*](#tfn4-ott-9-4053){ref-type="table-fn"}
  Total composite score      78.5±10.5               81.4±11.7                                               94.3±11.8[\*](#tfn4-ott-9-4053){ref-type="table-fn"}   95.6±13.2[\*](#tfn4-ott-9-4053){ref-type="table-fn"}
  Social composite score     72.7±12.1               75.8±9.5                                                92.4±13.1[\*](#tfn4-ott-9-4053){ref-type="table-fn"}   94.8±11.5[\*](#tfn4-ott-9-4053){ref-type="table-fn"}
  Physical composite score   60.5±7.3                68.2±8.8[\*\*](#tfn5-ott-9-4053){ref-type="table-fn"}   80.5±8.4[\*](#tfn4-ott-9-4053){ref-type="table-fn"}    90.6±13.2[\*](#tfn4-ott-9-4053){ref-type="table-fn"},[\*\*](#tfn5-ott-9-4053){ref-type="table-fn"}

**Notes:** All values are given in mean ± SD.

*P*\<0.05 vs 1 month after surgery.

*P*\<0.05 vs the control group.

**Abbreviations:** UW-QOL, University of Washington Quality of Life; SD, standard deviation.

###### 

PSAQ and SF-36 questionnaire scores

  Factor     1 month after surgery   6 months after surgery                                                                                          
  ---------- ----------------------- ------------------------------------------------------ -------------------------------------------------------- ----------------------------------------------------------------------------------------------------
  PSAQ A     24.3±5.8                19.5±4.7[\*](#tfn8-ott-9-4053){ref-type="table-fn"}    18.6±6.2[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}    13.4±5.8[\*](#tfn8-ott-9-4053){ref-type="table-fn"},[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}
  PSAQ C     14.5±6.4                12.5±5.1                                               8.5±4.3[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}     7.8±6.2[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}
  PSAQ SA    20.5±6.5                19.8±5.4                                               12.7±5.9[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}    11.2±4.3[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}
  PSAQ SC    16.8±4.2                10.7±3.1[\*](#tfn8-ott-9-4053){ref-type="table-fn"}    9.5±2.8[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}     5.8±2.1[\*](#tfn8-ott-9-4053){ref-type="table-fn"},[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}
  SF-36 PF   75.4±10.2               78.5±18.4                                              95.1±12.5[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}   98.3±15.8[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}
  SF-36 RP   42.3±8.4                60.3±15.3[\*](#tfn8-ott-9-4053){ref-type="table-fn"}   79.5±17.7[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}   94.2±23.1[\*](#tfn8-ott-9-4053){ref-type="table-fn"},[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}
  SF-36 BP   45.7±11.2               79.2±19.3[\*](#tfn8-ott-9-4053){ref-type="table-fn"}   83.8±14.4[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}   92.8±19.8[\*](#tfn8-ott-9-4053){ref-type="table-fn"},[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}
  SF-36 GH   52.8±10.8               68.5±21.4[\*](#tfn8-ott-9-4053){ref-type="table-fn"}   79.8±12.2[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}   90.8±26.1[\*](#tfn8-ott-9-4053){ref-type="table-fn"},[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}
  SF-36 VT   55.2±10.3               57.2±11.5                                              83.3±19.5[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}   87.4±23.7[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}
  SF-36 SF   68.3±12.5               70.2±18.5                                              85.1±18.4[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}   88.5±21.4[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}
  SF-36 RE   51.3±18.5               50.5±21.2                                              82.3±25.1[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}   82.4±31.8[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}
  SF-36 MH   63.8±11.4               65.3±17.2                                              83.1±18.5[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}   87.2±22.7[\*\*](#tfn9-ott-9-4053){ref-type="table-fn"}

**Notes:** All values are given in mean ± SD.

*P*\<0.05 vs the control group.

*P*\<0.05 vs 1 month after surgery.

**Abbreviations:** PSAQ, Patient Scar Assessment Questionnaire; A, appearance; C, consciousness; SA, satisfaction with appearance; SC, satisfaction with symptoms; SF-36, 36-Item Short Form Health Survey; PF, physical functioning; RP, role physical; BP, bodily pain; GH, general health; VT, vitality; SF, social functioning; RE, role-emotional; MH, mental health.
